Cargando…

Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study

OBJECTIVE: To investigate the effect of twice-daily rabeprazole doses on health-related quality of life in refractory patients. METHODS AND PATIENTS: Reflux esophagitis patients with an insufficient response to once-daily proton pump inhibitor therapy (Los Angeles Classification grade A-D) received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Yoshikazu, Hongo, Michio, Kusano, Motoyasu, Furuhata, Yoshinori, Miyagishi, Hideaki, Ikeuchi, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491805/ https://www.ncbi.nlm.nih.gov/pubmed/28502925 http://dx.doi.org/10.2169/internalmedicine.56.7896

Ejemplares similares

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

A Multicenter, Randomized, Open-Label Trial: Efficacy of Once-Daily Versus Twice-Daily Double-Dose Rabeprazole on Refractory Gastroesophageal Reflux Disease-Related Symptoms and Quality of Life
por: Mizuki, Akira, et al.
Publicado: (2016)

Rabeprazole Coadministration Controls Ulcer Recurrence in Patients on Low-dose Aspirin Therapy: A Multicenter Prospective Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2022)

Ten mg dexrabeprazole daily is as effective as 20 mg rabeprazole daily
por: Kanakia, Rajendra, et al.
Publicado: (2008)

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis
por: Nagahara, Akihito, et al.
Publicado: (2013)

Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24-hour Esophageal Impedance and pH Monitoring
por: Kawamura, Osamu, et al.
Publicado: (2016)

The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013)

Management of refractory and complicated reflux esophagitis.
por: Hirschowitz, B. I.
Publicado: (1996)

Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison
por: Furuta, Kenji, et al.
Publicado: (2014)

Open-Label Observational Study for Evaluating the Short-term Benefits of Rabeprazole Medication on Laryngopharyngeal Reflux
por: Shin, Myung-Hee, et al.
Publicado: (2012)

A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease
por: Zhang, Hongying, et al.
Publicado: (2017)

Vertical and Circumferential Localization of Esophageal Mucosal Breaks in Patients with Mild Reflux Esophagitis
por: Adachi, Kyoichi, et al.
Publicado: (2018)

An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease
por: Zouboulis-Vafiadis, Irini, et al.
Publicado: (2014)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone
por: Iida, Hiroshi, et al.
Publicado: (2017)

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes
por: Samuels, Stuart E., et al.
Publicado: (2017)

The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease
por: Shida, Hiroshi, et al.
Publicado: (2013)

Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux
por: Morita, Terumi, et al.
Publicado: (2012)

Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers
por: Ishimura, Norihisa, et al.
Publicado: (2015)

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis
por: Xia, X. M., et al.
Publicado: (2013)

Practical guide to choosing dabigatran 150 mg twice daily or apixaban 5 mg twice daily for patients with atrial fibrillation
por: Kobayashi, Zen, et al.
Publicado: (2019)

Retrospective Analysis of Eosinophilic Esophagitis in Patients with Refractory Gastroesophageal Reflux Disease
por: Anis, Khurram, et al.
Publicado: (2019)

Generation of Gastroesophageal Reflux Disease Symptoms During Esophageal Acid Infusion With Concomitant Esophageal pH Monitoring in Healthy Adults
por: Ohara, Shunji, et al.
Publicado: (2013)

Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease
por: Yamashita, Hiroshi, et al.
Publicado: (2018)

Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito
por: Sakata, Yasuhisa, et al.
Publicado: (2014)

Different gastoroesophageal reflux symptoms of middle-aged to elderly asthma and chronic obstructive pulmonary disease (COPD) patients
por: Shimizu, Yasuo, et al.
Publicado: (2012)

Assessment of the Multiple Rapid Swallows Test for Gauging Esophageal Reflux Burden in Patients with Refractory Gastroesophageal Reflux Disease
por: Chen, Jing, et al.
Publicado: (2021)

In Vitro Effects of Rabeprazole on Human Pylorus Tone
por: Yaşar, Necdet Fatih, et al.
Publicado: (2015)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

A multicenter randomized trial comparing rabeprazole and itopride in patients with functional dyspepsia in Japan: the NAGOYA study
por: Kamiya, Takeshi, et al.
Publicado: (2017)

Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms
por: Jiang, Liuqin, et al.
Publicado: (2017)

Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial
por: Fujishiro, Mitsuhiro, et al.
Publicado: (2015)

Stability-indicating HPLC–DAD methods for determination of two binary mixtures: Rabeprazole sodium–mosapride citrate and rabeprazole sodium–itopride hydrochloride
por: El-Fatatry, Hamed M., et al.
Publicado: (2014)

Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis
por: Fukuda, Naoki, et al.
Publicado: (2017)

A review of rabeprazole in the treatment of acid-related diseases
por: Pace, Fabio, et al.
Publicado: (2007)

Effect of rabeprazole on the transport and distribution of levofloxacin in rat stomachs
por: BAO, JUNJUN, et al.
Publicado: (2014)

Multiple widespread fixed drug eruption caused by rabeprazole
por: Gupta, S, et al.
Publicado: (2020)

Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers
por: Chan, Noel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4ighav2mr41r47ivct4a5rk3p